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Wherefore Art Thou, YY1?
Wendy B. Bollag1,2 and Roni J. Bollag3
In this issue, Taguchi et al. demonstrate that the transcription factor Yin Yang-1 
(YY1) regulates proliferation in three-dimensional cultures of the HaCaT human 
keratinocyte cell line. HaCaT keratinocytes overexpressing YY1 form artificial epi-
dermal constructs that are thicker than those produced from vector-transfected 
cells. RNA interference-mediated YY1 knockdown decreases the thickness of YY1-
overexpressing constructs, indicating that YY1 mediates the thickening. In primary 
keratinocytes, overexpressed YY1 also inhibits differentiation marker expression 
induced by calcium, supporting the idea that YY1 is important in regulating epider-
mal structure and function.
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The transcription factor Yin Yang-1 (YY1) 
is so named because this protein was first 
identified as a factor that in the absence of 
adenoviral E1A repressed transcription of 
the adenoviral-associated viral promoter 
but in the presence of E1A activated its 
transcription (reviewed in Gordon et al., 
2006). YY1, a member of the zinc-finger 
Gli-Krüppel family of transcription fac-
tors, seems to be expressed ubiquitously 
and conserved from Xenopus to humans, 
with a series of eight splice variants of 
unknown function in humans (Gordon 
et al., 2006). The Drosophila homolog 
of YY1 is pleiohomeotic, a member of 
the polycomb group family of homeotic 
gene repressors (Affar et al., 2006). YY1 
is reported to regulate the expression of 
various genes (Gordon et al., 2006; Shi 
et al., 1997), in some cases activating 
and in others repressing gene transcrip-
tion. Several models have been proposed 
to explain the mechanism by which YY1 
exerts these effects; in many cases YY1 
appears to interact directly with compo-
nents of the transcription machinery and/
or other transcription factors (Gordon 
et al., 2006).
In mice, a global lack of the YY1 gene 
results in embryonic (peri-implantation) 
lethality. Interestingly, Shi and colleagues 
used a combination of hypomorphic 
and floxed alleles to generate animals 
expressing 25, 50, or 75% of the normal 
amount of YY1 protein (Affar et al., 2006). 
These investigators demonstrated dosage-
dependent effects of YY1 gene/protein 
expression on embryogenesis, with 
about one half of the embryos having a 
YY1 level 25% of that of wild-type mice 
dying during late fetal develop ment. 
The mice that survived until parturition 
weighed less than wild-type littermates 
(approx imately 80% of the weight of the 
wild-type animals), appeared pale and 
slightly cyanotic, and died within a day 
of birth. Necropsies revealed that the 
lungs failed to inflate in these animals. 
The possibility of a skin phenotype was 
not investigated, although it is tempting 
to speculate, particularly in view of the 
work presented by Taguchi et al. in this 
issue, that closer examination might 
reveal epidermal abnormalities as well. 
In future studies, this floxed YY1 mouse 
model may prove useful in determining 
the role of YY1 in epidermal structure 
and function.
YY1 has been reported to regulate 
cell cycle progression: a decrease in 
levels of YY1 using a hypomorphic 
allele as described above, ablation of 
a floxed gene by Cre recombinase, or 
RNA interference-mediated knockdown 
leads to a reduction in proliferation in 
mouse embryo fibroblasts and cervical 
carcinoma (HeLa) cells (Affar et al., 
2010). Indeed, complete loss of the 
gene appears to block cytokinesis, and 
microarray analyses of reduced (25%) 
YY1-expressing compared with wild-
type mouse embryo fibroblasts revealed 
an upregulation of 231 genes and a 
decrease in 293 genes (Affar et al., 2006), 
many of which are known to be involved 
in modulating growth. Consistent with 
these findings, Taguchi et al. (2011) 
demonstrate that overexpression of full-
length YY1 in HaCaT human epidermal 
keratinocytes induces proliferation and 
results in a thickening of an artificial epi-
dermis reconstituted from these cells. 
In addition, YY1 overexpression sup-
presses expression of several differen-
tiation markers, including keratins 1 and 
10, involucrin, and filaggrin, supporting 
YY1’s reported ability to repress the pro-
moter activity of the differentiation mark-
ers involucrin (Alvarez-Salas et al., 2005) 
and loricrin (Xu et al., 2004). It should 
be noted that the investigators use the 
HaCaT cell line, a spontaneously immor-
talized keratinocyte cell line generated 
from adult human skin under conditions 
of low calcium (0.2 mM)-containing 
medium and elevated temperature (38.5 
°C). The HaCaT cells do not recapitulate 
normal differentiation entirely, in that the 
cells express differentiation markers but 
at the same time continue to prolif erate 
in high-calcium medium (Boukamp 
et al., 1988). (Taguchi et al. also note a 
lack of loricrin immunoreactivity in the 
HaCaT-derived artificial epidermis.) 
Nevertheless, the results were replicated 
in two-dimensional primary cultures 
of mouse epidermal keratinocytes, in 
which overexpression of YY1 inhibited 
the elevated extracellular calcium 
concentration-induced expression of 
several differentiation markers (keratin 1, 
involucrin, and loricrin; Taguchi et al., 
2011). Accordingly, the importance of 
YY1 in regulating epidermal keratinocyte 
function does not appear to be limited 
to a single species or to immortalized 
keratinocytes.
A second caveat is that the artificial 
epidermal constructs used in this study 
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were derived from a clonal population 
of YY1-overexpressing keratinocytes 
(Taguchi et al., 2011). It remains pos-
sible that any observed differences in 
proliferation and/or thickness result from 
clonal variations rather than from over-
expression of YY1. However, this con-
cern is largely obviated by the results 
obtained with RNA interference. Thus, 
lentiviral short hairpin RNA-mediated 
knockdown of the overexpressed YY1 
returns the artificial epidermis to a thick-
ness similar to that of the control, and 
differentiation markers are re-expressed, 
suggesting that the differences observed 
are, in fact, due to overexpressed YY1, 
and providing evidence that YY1 pro-
motes proliferation and inhibits differ-
entiation of epidermal keratinocytes.
A question that remains is whether 
YY1 is related to human skin disease. 
Accumulating evidence supports a 
role for YY1 in several human cancers, 
including various epithelial malignancies 
such as prostate, ovarian, breast, cervical, 
colon, and lung cancers (Castellano et 
al., 2009). Other members of the Gli-
Krüppel family of transcription factors 
(e.g., Gli1 and Gli2) are involved in the 
development of several skin tumors, 
including basal cell carcinoma, basa-
loid follicular hamartoma, cylindroma, 
and trichoblastoma (Sheng et al., 2002), 
and Gli-similar 1 (Glis1) expression is 
upregulated in psoriasis (Nakashani 
et al., 2006). Finally, Kawada et al. have 
demonstrated that YY1 functions with 
another transcription factor, Sp1, to 
transactivate the gene ATP2C1, which 
encodes for a Golgi-localized calcium 
ATPase (Kawada et al., 2005). Mutations 
in this gene and/or loss of protein expres-
sion result in Hailey–Hailey disease, an 
autosomal dominant blistering skin dis-
ease characterized by insufficient cell–
cell adhesion among suprabasal kerati-
nocytes. Because YY1, together with Sp1, 
increases the expression of ATP2C1, it 
seems possible that congenital deficiency 
of YY1 may contribute to the etiology of 
Hailey–Hailey disease in some patients. 
Therefore, additional studies are war-
ranted in order to define the role and 
mechanism of action of YY1 in regulating 
keratinocyte structure and function.
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eczema across the World: The Missing 
Piece of the Jigsaw Revealed
Hywel C. Williams1
Cleverly using records obtained from the 2003 National survey of Children’s Health 
(NsCH), shaw et al. provide a pioneering glimpse into the burden of eczema across 
the United states. Using parental reports of a doctor’s diagnosis of eczema in the 
past 12 months, the authors show that eczema affects around 9–18% of children 
age 17 and under. The study confirms reported associations such as living in metro-
politan areas, higher household education level, and black ethnicity. Novel findings 
include the demonstration of higher eczema prevalence along the east Coast. The 
study correlates well with previous reports and may help point to environmental 
factors that contribute to the development of eczema.
Journal of Investigative Dermatology (2011) 131, 12–14. doi:10.1038/jid.2010.333
One of the most striking features about 
world maps of eczema (atopic derma titis) 
prevalence derived from the International 
Study of Asthma and Allergies in 
Childhood (ISAAC), which involved more 
than 1 million children from 230 centers 
in 97 countries (Figure 1), is the almost 
complete absence of data from the 
